TABLE 3.
Summary of Doses of Asparaginase Received per Phase for S-PEG and I-PEG Treatment Groups
| S-PEG | I-PEG | |||||
|---|---|---|---|---|---|---|
| Reporting Period | Starting RP | Off Tx during RP | Received 2 doses of PEG in RP | Starting RP | Off Tx during RP | Received ≥ 4 doses of PEG in RP |
| Consolidation | 54 | 0 | 41 | 30 | 12 | 18 |
| IM | 54 | 0 | 36 | 18 | 0 | 14 |
| DI | 54 | 1 | 34 | 18 | 3 | 11 |
RP: reporting period